Emil Miskovsky, MD
Gastroenterology · Lewiston, MENPI 1427043942
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,142 and has fallen 98.3% since, to $20 in 2025.
Across 98 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$423
- Pfizer$307
- QOL Medical, LLC$176
- Takeda Pharmaceuticals U.S.A., Inc.$138
- Ambu Inc.$134
- Cook Medical LLC$131
- plus $604 from 12 others
What the payments were for
- Food & beverage$1,914100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $423 |
| Pfizer | 25 | $307 |
| QOL Medical, LLC | 6 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $138 |
| Ambu Inc. | 1 | $134 |
| Cook Medical LLC | 2 | $131 |
| UCB, Inc. | 6 | $111 |
| Janssen Scientific Affairs, LLC | 2 | $111 |
| Johnson & Johnson | 6 | $87 |
| Steris Corporation | 1 | $82 |
| Merck | 4 | $56 |
| Braintree Laboratories, Inc. | 2 | $34 |
| Redhill Biopharma Inc. | 1 | $25 |
| AstraZeneca | 1 | $23 |
| Gilead | 2 | $22 |
| Capsovision, Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
How this compares
$1,914 in reported general payments places this provider in the 70th percentile of 68 gastroenterology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 192 | $3,005 |
| Sucralfate | 12 | $2,399 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 100 | $2,172 |
| Pantoprazole Sodium | 41 | $523 |
| Omeprazole | 18 | $345 |
| Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg | 14 | $176 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Lewiston
- Winoah HenryLewiston$13K
- Benjamin SteinLewiston$4K
- Oswaldo BisbalLewiston$2K
- John MladuckyLewiston$2K
- John LewandowskiLewiston$250
- Catherine McCrannLewiston$146
- Douglas HowellPortland$1.2M
- Martin MoehlenPortland$340K
- Tahira SaifuddinBangor$84K
- Brian BerberianBangor$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.